Here are the trades in HART during the regular session on Friday:
This is a very thinly traded stock, so it doesn't take much to swing the pps.
You obviously know nothing about this company.
Construction is booming here in FL..In addition, many insurance companies are now requiring windows in existing homes to meet current hurricane code.
I bought more shares to average down today.
Although they are debt heavy, there is a good chaance for a rebound in oil later this year.
08:30 $ 12.29 200
08:24 $ 12.33 1,000
08:22 $ 12.35 High 5
08:22 $ 12.35 High 900
08:22 $ 12.25 5
08:22 $ 11.95 281
08:20 $ 12.07 5
08:20 $ 12.25 1,000
08:16 $ 11.94 Low 300
08:16 $ 11.94 Low 100
08:10 $ 11.96 100
08:06 $ 11.94 200
Here is what he said:
"I am very pleased to report that the U.S. launch of Auryxia is progressing as planned, with a good reception to date from both payers and providers," said Greg Madison, President and Chief Operating Officer. "We are well on our way to achieving the goal of broad unrestricted access for Part D and commercial payers within several months."
Yes...they had $85M in cash at YE and after expenses another $110K from the 2015 offering...less what they have spent in Jan/Feb.
As i said, wait for the CC at 8AM before listiening to MBs.
Or..they are looking at the prior quarter results and not looking forward.
I'll take the uptick in price and sold a few shares...kept most for the long haul.
I like the CEO.
Read the artcile in today's WSJ..look at the balance sheet after the SLXP deal.
Someone will acquire PGNX..just not Valeant.
I think Valeant will have to reduce debt after the SLXP deal..
i wouldn't count on them as an acquirer of PGNX.
Where is the article about Dr. M and professional misconduct?
I would think Mayo did their own DD concerning the players involved in the partnership.
Sentiment: Strong Buy
Good news and the share price doesn't take a bounce...go figure.
I bought the stock after the Amazon deal was announced.
DepoMed: Expects to Raise Remaining Capital Through Debt, Equity and Equity-linked Financing
They will have to raise the money to pay for this by the 3 ways cited in their press release.
It will be a good investment for DepoMed long term.
There is an article in Propthink today that mentioned the CBST buyout and the TTPH/CEMP possibilities for buyouts. This explains the uptick in TTPH..someone always knows the news ahead of time...
Sentiment: Strong Buy